Home
Categories
Ingredients
Research & Development
Manufacturing
Packaging
Active Nutrition
Cardiovascular
Digestion
Cognitive
Finance
Regulatory
Company News
Events
Directory
Search
Close search
Home
Company
Open Book Extracts
Open Book Extracts
Activities:
Ingredients
X
LinkedIn
Trending Articles
The perfect pair: how vitamins K2 and D3 combine to support health and well-being
Hydrogen and oxygen, Yin and Yang, Batman and Robin; the world is full of iconic duos that combine to become more than the sum of their parts. One relatively unknown yet...
Degradation of vitamins, probiotics and other active ingredients caused by exposure to heat, water and sunlight
Vitamins and probiotics (and other active ingredients) can be substantially affected by exposure to heat, water and/or sunlight
The role of traceability in the nutraceutical supply chain
The exponential growth of the nutraceutical sector, combined with the unprecedented growth in online marketplaces, makes nutraceuticals highly vulnerable to vast counterfeiting...
GOED releases two market research reports: annual global omega-3 ingredient market and consumer search trends
The Global Organization for EPA and DHA Omega-3s (GOED) has published two important reports detailing trends in the global EPA and DHA omega-3 industry
How to treat (and supplement) pets like part of the family
Globally, 85% of pet parents agree that proper nutrition and supplements are as important for their pets as they are for themselves, writes Guillaume Maio, Marketing Manager,...
Upcoming event
Vitafoods Europe
14–16 May 2024 | Exhibition | Palexpo, Geneva
See all
Related Content
Ingredients
Open Book Extracts (OBX) announces founding membership in ONE HEMP
Since the inception of Open Book Extracts (OBX) in 2019, the company has served as a leader in the hemp-based CBD market, prioritising science, safety, and responsible commerce
Ingredients
OBX launches trial for minor cannabinoid formulations
The cannabinoids selected were CBD, CBG, CBC, and CBDV, and the polyphenols selected were Quercetin and Curcumin
Finance
OBX receives strategic investment from Btomorrow Ventures
The two companies have signed a scientific collaboration agreement covering areas of future R&D
Ingredients
Open Book Extracts expands capabilities and management team to boost finished goods manufacturing
The expansion will serve to address increased demand for the company’s product development and manufacturing services
Regulatory
OBX announces results of Phase I toxicology assessment
The company contracted AIBMR Life Sciences to conduct the studies investigating the safety of consuming its CBG, CBN, and CBC products
Ingredients
OBX completes trial of cannabinoids for pain relief
Results from the pain study are expected in late April 2022 and will be announced at that time
Ingredients
Open Book Extracts appoints European sales leadership
In March 2021, OBX became a member of the European Industrial Hemp Association Novel Food Consortium
Subscribe now